#184: Rivaroxaban gets ACS indication recommendation from European regulators; MitraClip narrowly passes major test with FDA advisory panel; new oral anticoagulants in secondary stroke prevention: Apples and oranges?; EMA recommends restricting cilostazol

Rivaroxaban gets ACS indication recommendation from European regulators; MitraClip narrowly passes major test with FDA advisory panel; new oral anticoagulants in secondary stroke prevention: Apples and oranges?; EMA recommends restricting cilostazol

http://feedproxy.google.com/~r/radiotheheartorg/~3/QE8K_3FUJmA/184-rivaroxaban-g...

Source: Radio TheHeart.org - March 28, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts